“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one.
Delays in Diagnosis
This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors is really important.
Highlights from Tuesday and Wednesday day 3 and 4 of the ACR Annual meeting in Chicago, included:
Rheumatology Roundup - Drs. Artie Kavanaugh and Jack Cush
Pregnancy for patients with lupus has long been considered high risk and associated with both medical and obstetric complications, but outcomes have improved over the last 2 decades and continue to improve.